info@healthcostinstitute.org

mediA@healthcostinstitute.org

  • X
  • LinkedIn
  • Link
Search
Health Care Cost Institute
  • Home
  • Data
    • ESI Data Access Hub
    • Data Tools
    • Healthy Marketplace Index
    • Price Transparency Tool
  • Research
    • Original Reports
    • Health Care Cost & Utilization Report 
    • Health Care Vitals
    • Latest HCCI Reports
  • About HCCI
    • About Us
    • HCCI Staff
    • CEO & President
    • Careers
    • Governing Board 
Search

Wegovy

  • The Share of Ozempic Users with Diabetes has Decreased Over Time, Indicating Increased Off-label Use

    Tags: Drug Spending, Ozempic, Wegovy
    The Share of Ozempic Users with Diabetes has Decreased Over Time, Indicating Increased Off-label Use
    Bianca Silva Gordon, Aditi Sen, Daniel Kurowski
    June 14, 2023

    Ozempic, a relatively new anti-diabetes drug, has been in the headlines because of widespread shortages that are making it difficult for patients who use the drug to manage diabetes to access it. Some news articles suggest that off-label use for weight loss has been a factor associated with increased demand. The active ingredient in Ozempic is…

    Read more: The Share of Ozempic Users with Diabetes has Decreased Over Time, Indicating Increased Off-label Use
    • Facebook
    • X
    • LinkedIn
    • Pinterest

Enhance your research using customized data analysis

Are you interested in a specific health care topic? HCCI can use our commercial and government data resources and unique analytic experience to help you. Just reach out!

Partner with us

About

We are a mission-driven, independent, nonprofit organization situated at the nexus of data, analytics, and action.

Contact

1100 G Street NW, Suite 600
Washington DC, 20005

info@healthcostinstitute.org
media@healthcostinstitute.org

Research

HCCI Publications
Research Resources

Data

Data Access Hub
Data Tools

Quick Links

Partner with HCCI
HCCI Newsletter
Careers

  • LinkedIn
  • X
  • Link
  • Bluesky

© 2025 Health Care Cost Institute Inc.
Unless explicitly noted, the content on this website is licensed under a Creative Commons Attribution Non-Commercial No Derivatives 4.0 License

Scroll to Top